We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Staining Method for Electron Microscope Specimens Safer and Cost-Effective

By LabMedica International staff writers
Posted on 06 Jun 2022

The electron microscopic staining technique for biological specimens using uranyl acetate (UA) was first reported in 1958 and has been used in electron microscopy facilities worldwide because of its simplicity and optimal staining results. More...

In recent years, however, international regulations on the use, acquisition, storage, and disposal of uranium compounds have become increasingly strict because uranium is used as a nuclear material for weapons. Against this backdrop, alternative staining methods have long been long awaited in the field of biological research, and several have been proposed, but none has been an effective alternative. In this context, alternative staining methods have long been expected in the bio-medical electron microscopic research field, and several have been proposed, though none has been an effective alternative. Now, researchers have developed a new staining method for electron microscope specimens based on double staining with hematoxylin, which is widely used as a staining agent for light microscopy, and lead solution. The new method is expected to replace the conventional method of double staining with uranium acetate and lead solution and is a better choice in terms of safety, cost, and ease of handling.

To develop a safe and easy-to-handle alternative staining method to UA for ultrathin sectioning in electron microscopy, researchers at Tokyo University of Technology (Tokyo, Japan) examined various commercially available dyes for light microscopy. The researchers found that double staining with Mayer's hematoxylin (MH), which is commonly used as a staining agent in light microscopy, and lead solution (Pb), exhibited staining properties equivalent to those of conventional electron microscopic double staining with UA and Pb in various tissues and cells.

Other cell organelles, such as nuclear chromatin, plasma membrane structures, ribosomes, glycogen, lipid droplets, cell adhesion apparatus, and cytoskeletal system(s), were stained with high contrast using the MH staining method. Plasma membrane staining in all samples was also satisfactory. Backscattered electron images of 200 nm semi-thin sections of mouse kidney observed by a field emission scanning electron microscope also showed that the MH and Pb staining techniques provided a wide-area and high-quality image of the renal cortical tubules and the renal glomerulus.

MH is a dye solution widely used for staining paraffin sections of diagnostic clinical specimens, and has the advantages of low cost, stable supply as a commercial product, and high safety of waste solution. On the other hand, the International Atomic Energy Agency's "International Basic Safety Standards for Protection against Ionizing Radiation and for the Safety of Radiation Sources" (BSS) has established specific exemption levels, and new regulations for radioactive materials are being developed internationally through legislation. Based on the results of this study, double staining with MH and Pb is expected to become a useful alternative to the staining method using radioactive UA in terms of reagent purchase, handling, use, storage, and liquid waste treatment.

Related Links:
Tokyo University of Technology 


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Collection and Transport System
PurSafe Plus®
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.